Tech Company Financing Transactions
Agios Pharmaceuticals Funding Round
Agios Pharmaceuticals, operating out of Cambridge, received $78 million in funding from Arch Venture Partners, Celgene and Flagship Pioneering.
Transaction Overview
Arch Venture Partners (Robert Nelson)
Celgene (Perry Karsen)
Flagship Pioneering (Douglas Cole)
Third Rock Ventures (Kevin Starr)
Company Information
Cambridge, MA 02139
USA
Management Team
Browse more venture capital transactions:
Prev: 11/17/2011: Impermium venture capital transaction
Next: 11/18/2011: UserVoice venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs